Skip to main content

Peritoneal Diseases

  • Chapter
  • First Online:
Diagnosis of Liver Disease

Abstract

The peritoneum is an organ of serosa with combined epithelial and mesenchymal features. It consists mainly of mesothelial cells arranged in a monolayer. Peritoneal disorders include primary or secondary tumors, benign or malignant tumors, and inflammatory disorders. Hence, they are not only of tuberculosis and sarcoidosis but also mesothelioma and carcinomatosis which can impair physiological functions [1] and produce massive ascites. Sclerosing encapsulating peritonitis leads to peritoneal fibrosis and obstruction of small intestine which mimics liver cirrhosis.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Abbreviations

BAP1:

Breast cancer-associated protein 1

CA125:

Carcinogenic antigen-125

CA19-9:

Carcinogenic antigen 19-9

FDG-PET:

18F-fluorodeoxyglucose positron emission tomography

SEP:

Sclerosing encapsulating peritonitis

TNF:

Tumor necrosis factor

TS-1:

Combination capsule of tegafur, gimeracil, and oteracil potassium

References

  1. van Baal JOAM, Van de Vijver KK, Nieuwland R, van Noorden CJF, van Driel WJ, Sturk A, Kenter GG, Rikkert LG, Lok CAR. The histophysiology and pathophysiology of the peritoneum. Tissue Cell. 2017;49:95–105.

    Article  PubMed  Google Scholar 

  2. Uzunkoy A, Harma M, Harma M. Diagnosis of abdominal tuberculosis: experience from 11 cases and review of the literature. World J Gastroenterol. 2004;10:3647–9.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Sanai FM, Bzeizi KI. Systematic review: tuberculous peritonitis—presenting features, diagnostic strategies and treatment. Aliment Pharmacol Ther. 2005;22:685–700.

    Article  CAS  PubMed  Google Scholar 

  4. Malik A, Saxena NC. Ultrasound in abdominal tuberculosis. Abdom Imaging. 2003;28:574–9.

    Article  CAS  PubMed  Google Scholar 

  5. Sinan T, Sheikh M, Ramadan S, Sahwney S, Behbehani A. CT features in abdominal tuberculosis: 20 years-experience. BMC Med Imaging. 2002;2:3–16.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Shimamoto H, Hamada K, Higuchi I, et al. Abdominal tuberculosis: peritoneal involvement shown by F-18 FDG PET. Clin Nucl Med. 2007;32:716–8.

    Article  PubMed  Google Scholar 

  7. Riquelme A, Calvo M, Salech F, Valderrama S, Pattillo A, Arellano M, et al. Value of adenosine deaminase (ADA) in ascitic fluid for the diagnosis of tuberculous peritonitis: a meta-analysis. J Clin Gastroenterol. 2006;40:705–10.

    Article  CAS  PubMed  Google Scholar 

  8. Henning H, Lightdale CJ, Look D. Color atlas of diagnostic laparoscopy. New York: Thieme Medical Publishers; 1994. p. 199–200.

    Google Scholar 

  9. Milingos S, Protopapas A, Papadimitriou C, Rodolakis A, Kallipolitis G, Skartados N, et al. Laparoscopy in the evaluation of women with unexplained ascites: an invaluable diagnostic tool. J Minim Invasive Gynecol. 2007;14:43–8.

    Article  PubMed  Google Scholar 

  10. Jorge AD. Peritoneal tuberculosis. Endoscopy. 1984;16:10–2.

    Article  CAS  PubMed  Google Scholar 

  11. Gezer NS, Başara I, Altay C, Harman M, Rocher L, Karabulut N, et al. Abdominal sarcoidosis: cross-sectional imaging findings. Diagn Interv Radiol. 2015;21:111–7.

    Article  PubMed  Google Scholar 

  12. Kurdziel KA. The panda sign. Radiology. 2000;215:884–5.

    Article  CAS  PubMed  Google Scholar 

  13. Kunishi Y, Yoshie K, Ota M, Kuboi Y, Kanno M, Tanaka S, et al. Peritoneal sarcoidosis: an unusual cause of ascites. Nihon Shokakibyo Gakkai Zasshi. 2016;113:143–51.

    Google Scholar 

  14. Warshauer DM, Molina PL, Hamman SM, Koehler RE, Paulson EK, Bechtold RE, et al. Nodular sarcoidosis of the liver and spleen: analysis of 32 cases. Radiology. 1995;195:757–62.

    Article  CAS  PubMed  Google Scholar 

  15. Warshauer DM, Lee JKT. Imaging manifestations of abdominal sarcoidosis. Am J Roentgenol. 2004;182:15–28.

    Article  Google Scholar 

  16. Judson MA. Advances in the diagnosis and treatment of sarcoidosis. F1000Prime Rep. 2014;6:89–65.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  17. Dasilva V, Breuil V, Chevallier P, Euller-Ziegler L. Relapse of severe sarcoidosis with uncommon peritoneal location after TNF-alpha blockade. Efficacy of rituximab: report of a single case. Joint Bone Spine. 2010;77:82–3.

    Article  PubMed  Google Scholar 

  18. Foo KT, Ng KC, Rauff A, Foong WC, Sinniah R. Unusual small intestinal obstruction in adolescent girls: the abdominal cocoon. Br J Surg. 1978;65:427–30.

    Article  CAS  PubMed  Google Scholar 

  19. Akbulut S. Accurate definition and management of idiopathic sclerosing encapsulating peritonitis. World J Gastroenterol. 2015;21:675–87.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Tannoury JN, Abboud BN. Idiopathic sclerosing encapsulating peritonitis: abdominal cocoon. World J Gastroenterol. 2012;18:1999–2004.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Li N, Zhu W, Li Y, Gong J, Gu L, Li M, Cao L, Li J. Surgical treatment and perioperative management of idiopathic abdominal cocoon: single-center review of 65 cases. World J Surg. 2014;38:1860–7.

    Article  PubMed  Google Scholar 

  22. George C, Al-Zwae K, Nair S, Cast JE. Computed tomography appearances of sclerosing encapsulating peritonitis. Clin Radiol. 2007;62:732–7.

    Article  CAS  PubMed  Google Scholar 

  23. Honda K, Oda H. Pathology of encapsulating peritoneal sclerosis. Perit Dial Int. 2005;25(Suppl 4):S19–29.

    Article  PubMed  Google Scholar 

  24. Habib SM, Betjes MG, Fieren MW, Boeschoten EW, Abrahams AC, Boer WH, et al. Management of encapsulating peritoneal sclerosis: a guideline on optimal and uniform treatment. Neth J Med. 2011;69:500–7.

    CAS  PubMed  Google Scholar 

  25. Yamamoto S, Sato Y, Takahashi T, Kobayashi T, Hatakeyama K. Sclerosing encapsulating peritonitis in two patients with liver cirrhosis. J Gastroenterol. 2004;39:172–5.

    Article  PubMed  Google Scholar 

  26. Averbach AM, Sugarbaker PH. Peritoneal mesothelioma: treatment approach based on natural history. Cancer Treat Res. 1996;81:193–211.

    Article  CAS  PubMed  Google Scholar 

  27. Friedman MT, Gentile P, Tarectecan A, Fuchs A. Malignant mesothelioma: immunohistochemistry and DNA ploidy analysis as methods to differentiate mesothelioma from benign reactive mesothelial cell proliferation and adenocarcinoma in pleural and peritoneal effusions. Arch Pathol Lab Med. 1996;120:959–66.

    CAS  PubMed  Google Scholar 

  28. Pickhardt PJ, Bhalla S. Primary neoplasms of peritoneal and sub-peritoneal origin: CT findings. Radiographics. 2005;25:983–95.

    Article  PubMed  Google Scholar 

  29. Park JY, Kim KW, Kwon HJ, Park MS, Kwon GY, Jun SY, et al. Peritoneal mesotheliomas: clinicopathologic features, CT findings, and differential diagnosis. AJR Am J Roentgenol. 2008;191:814–25.

    Article  PubMed  Google Scholar 

  30. Søreide JA, Søreide K, Körner H, Søiland H, Greve OJ, GudLaugsson E. Benign peritoneal cystic mesothelioma. World J Surg. 2006;30:560–6.

    Article  PubMed  Google Scholar 

  31. Nasu M, Emi M, Pastorino S, et al. High incidence of somatic BAP1 alterations in sporadic malignant mesothelioma. J Thorac Oncol. 2015;10(2):565–76.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Cercek A, Zaderer M, Rimner A, et al. Confirmation of high prevalence of BAP1 inactivation in mesothelioma. J Clin Oncol. 2015;33(Suppl):Abstract 7564.

    Article  Google Scholar 

  33. Vogelzang NJ, Rusthoven JJ, Symanowski J, Denham C, Kaukel E, Ruffie P, et al. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol. 2003;21:2636–44.

    Article  CAS  PubMed  Google Scholar 

  34. Hassan R, Alexander R, Antman K, Boffetta P, Churg A, Coit D, et al. Current treatment options and biology of peritoneal mesothelioma: meeting summary of the first NIH peritoneal mesothelioma conference. Ann Oncol. 2006;17:1615–9.

    Article  CAS  PubMed  Google Scholar 

  35. Mohamed F, Sugarbaker PH. Peritoneal mesothelioma. Curr Treat Options Oncol. 2002;3:375–86.

    Article  PubMed  Google Scholar 

  36. Baratti D, Kusamura S, Cabras AD, Dileo P, Laterza B, Deraco M. Diffuse malignant peritoneal mesothelioma: failure analysis following cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC). Ann Surg Oncol. 2009;16:463–72.

    Article  CAS  PubMed  Google Scholar 

  37. Kim J, Bhagwandin S, Labow DM. Malignant peritoneal mesothelioma: a review. Ann Transl Med. 2017;5:236–46.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Muntean V, Mihailov A, Iancu C, Toganel R, Fabian O, Domsa I, et al. Staging laparoscopy in gastric cancer. Accuracy and impact on therapy. J Gastrointestin Liver Dis. 2009;18:189–95.

    PubMed  Google Scholar 

  39. del Castillo CF, Warshaw L. Peritoneal metastases in pancreatic carcinoma. Hepatogastroenterology. 1993;40:430–2.

    PubMed  Google Scholar 

  40. Groutz A, Carmon E, Gat A. Peritoneal tuberculosis versus advanced ovarian cancer: a diagnostic dilemma. Obstet Gynecol. 1998;91:868.

    CAS  PubMed  Google Scholar 

  41. Suzuki A, Kawano T, Takahashi N, Lee J, Nakagami Y, Miyagi E, et al. Value of 18F-FDG PET in the detection of peritoneal carcinomatosis. Eur J Nucl Med Mol Imaging. 2004;31:1413–20.

    Article  PubMed  Google Scholar 

  42. Pomel C, Provencher D, Dauplat J, Gauthier P, Le Bouedec G, Drouin P, et al. Laparoscopic staging of early ovarian cancer. Gynecol Oncol. 1995;58:301–6.

    Article  CAS  PubMed  Google Scholar 

  43. Sharma V, Rana SS, Ahmed SU, Guleria S, Sharma R, Gupta R. Endoscopic ultrasound fine-needle aspiration from ascites and peritoneal nodules: a scoping review. Endosc Ultrasound. 2017;6:382–8.

    Article  PubMed  PubMed Central  Google Scholar 

  44. Koizumi W, Tanabe S, Saigenji K, Ohtsu A, Boku N, Nagashima F, et al. Phase I/II study of S-1 combined with cisplatin in patients with advanced gastric cancer. Br J Cancer. 2003;89:2207–12.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Masaki Iwai MD, PhD .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Iwai, M., Kunishi, Y., Suriawinata, A.A. (2019). Peritoneal Diseases. In: Hashimoto, E., Kwo, P., Suriawinata, A., Tsui, W., Iwai, M. (eds) Diagnosis of Liver Disease. Springer, Singapore. https://doi.org/10.1007/978-981-13-6806-6_20

Download citation

  • DOI: https://doi.org/10.1007/978-981-13-6806-6_20

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-13-6805-9

  • Online ISBN: 978-981-13-6806-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics